SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Capricor Therapeutics Q1 EPS $(0.300) Down From $(0.080) YoY

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.300) per share. This is a 275 percent decrease over losses of $(0.080) per share from the same period last year.

Benzinga · 05/13/2020 11:07

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.300) per share. This is a 275 percent decrease over losses of $(0.080) per share from the same period last year.